Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Apr;91(4):1649–1655. doi: 10.1172/JCI116373

Crystal-induced neutrophil activation. III. Inflammatory microcrystals induce a distinct pattern of tyrosine phosphorylation in human neutrophils.

M Gaudry 1, C J Roberge 1, R de Médicis 1, A Lussier 1, P E Poubelle 1, P H Naccache 1
PMCID: PMC288143  PMID: 8386191

Abstract

The activation of human neutrophils by monosodium urate and calcium pyrophosphate dihydrate crystals is believed to play a critical role in the pathogenesis of arthritides such as acute gout and pseudogout, respectively. In this study, we investigated the potential involvement of tyrosine phosphorylation in microcrystal-mediated activation of human neutrophils. Immunoblot analysis with antiphosphotyrosine antibodies demonstrated that triclinic monosodium urate and calcium pyrophosphate dihydrate crystals stimulated a time- and concentration-dependent tyrosine phosphorylation of at least five proteins (pp130, 118, 80, 70, and 60). While phosphoprotein (pp) 118 and pp70 were the major phosphorylated substrates, pp70 was the dominant one in reactivity with antiphosphotyrosine antibodies. When the temporal patterns, as well as the levels of tyrosine phosphorylation for both types of crystals were compared, monosodium urate crystals were found to be more potent activators than calcium pyrophosphate dihydrate crystals. The tyrosine phosphorylation patterns induced by microcrystals differed from those stimulated by other soluble (FMLP, C5a, or leukotriene B4) or particulate (unopsonized latex beads or zymosan) agonists which stimulated preferentially the tyrosine phosphorylation of pp118. The ratio of the intensities of pp118 and pp70 were specific of the stimulation with microcrystals when compared to those observed with the other soluble or particulate agonists. Colchicine, a drug used specifically in the treatment of gout and pseudogout, inhibited microcrystal-induced tyrosine phosphorylation, while beta- and gamma-lumicolchicine were without effect. On the other hand, colchicine failed to inhibit FMLP-induced tyrosine phosphorylation. Furthermore, while colchicine inhibited the activation of the NADPH oxidase by microcrystals, it, on the other hand, enhanced the production of superoxide anions by FMLP. Taken together, these results (a) demonstrate that tyrosine phosphorylation is involved in the mechanism of activation of human neutrophils induced by microcrystals; and (b) suggest, on the basis of the characteristics of the observed patterns of tyrosine phosphorylation, that this response may be specific to the microcrystals and relevant to their phlogistic properties.

Full text

PDF
1649

Images in this article

1651Image
on p.1651
1651Image
on p.1651
1652Image
on p.1652
1653Image
on p.1653
1653Image
on p.1653
1653Image
on p.1653

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson S., Hoffstein S. T., Weissmann G. Superoxide anion generation by human neutrophils exposed to monosodium urate. Arthritis Rheum. 1982 Feb;25(2):174–180. doi: 10.1002/art.1780250210. [DOI] [PubMed] [Google Scholar]
  2. Antommattei O., Heimer R., Baker D. G., Schumacher H. R., Jr Binding of synovial fluid proteins to monosodium urate crystals in vitro. Clin Exp Rheumatol. 1990 Jan-Feb;8(1):29–34. [PubMed] [Google Scholar]
  3. Berkow R. L., Dodson R. W. Tyrosine-specific protein phosphorylation during activation of human neutrophils. Blood. 1990 Jun 15;75(12):2445–2452. [PubMed] [Google Scholar]
  4. Bomalaski J. S., Baker D. G., Brophy L. M., Clark M. A. Monosodium urate crystals stimulate phospholipase A2 enzyme activities and the synthesis of a phospholipase A2-activating protein. J Immunol. 1990 Nov 15;145(10):3391–3397. [PubMed] [Google Scholar]
  5. Burt H. M., Jackson J. K., Rowell J. Calcium pyrophosphate and monosodium urate crystal interactions with neutrophils: effect of crystal size and lipoprotein binding to crystals. J Rheumatol. 1989 Jun;16(6):809–817. [PubMed] [Google Scholar]
  6. Cantley L. C., Auger K. R., Carpenter C., Duckworth B., Graziani A., Kapeller R., Soltoff S. Oncogenes and signal transduction. Cell. 1991 Jan 25;64(2):281–302. doi: 10.1016/0092-8674(91)90639-g. [DOI] [PubMed] [Google Scholar]
  7. Denko C. W., Whitehouse M. W. Experimental inflammation induced by naturally occurring microcrystalline calcium salts. J Rheumatol. 1976 Mar;3(1):54–62. [PubMed] [Google Scholar]
  8. Famaey J. P. Colchicine in therapy. State of the art and new perspectives for an old drug. Clin Exp Rheumatol. 1988 Jul-Sep;6(3):305–317. [PubMed] [Google Scholar]
  9. Gaudry M., Caon A. C., Gilbert C., Lille S., Naccache P. H. Evidence for the involvement of tyrosine kinases in the locomotory responses of human neutrophils. J Leukoc Biol. 1992 Feb;51(2):103–108. doi: 10.1002/jlb.51.2.103. [DOI] [PubMed] [Google Scholar]
  10. Ginsberg M. H., Kozin F., Chow D., May J., Skosey J. L. Adsorption of polymorphonuclear leukocyte lysosomal enzymes to monosodium urate crystals. Arthritis Rheum. 1977 Nov-Dec;20(8):1538–1542. doi: 10.1002/art.1780200815. [DOI] [PubMed] [Google Scholar]
  11. Gomez-Cambronero J., Huang C. K., Bonak V. A., Wang E., Casnellie J. E., Shiraishi T., Sha'afi R. I. Tyrosine phosphorylation in human neutrophil. Biochem Biophys Res Commun. 1989 Aug 15;162(3):1478–1485. doi: 10.1016/0006-291x(89)90841-3. [DOI] [PubMed] [Google Scholar]
  12. Gomez-Cambronero J., Wang E., Johnson G., Huang C. K., Sha'afi R. I. Platelet-activating factor induces tyrosine phosphorylation in human neutrophils. J Biol Chem. 1991 Apr 5;266(10):6240–6245. [PubMed] [Google Scholar]
  13. Guerne P. A., Terkeltaub R., Zuraw B., Lotz M. Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum. 1989 Nov;32(11):1443–1452. doi: 10.1002/anr.1780321114. [DOI] [PubMed] [Google Scholar]
  14. Hoffstein S., Weissmann G. Mechanisms of lysosomal enzyme release from leukocytes. IV. Interaction of monosodium urate crystals with dogfish and human leukocytes. Arthritis Rheum. 1975 Mar-Apr;18(2):153–165. doi: 10.1002/art.1780180213. [DOI] [PubMed] [Google Scholar]
  15. Huang C. K., Bonak V., Laramee G. R., Casnellie J. E. Protein tyrosine phosphorylation in rabbit peritoneal neutrophils. Biochem J. 1990 Jul 15;269(2):431–436. doi: 10.1042/bj2690431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kraft A. S., Berkow R. L. Tyrosine kinase and phosphotyrosine phosphatase activity in human promyelocytic leukemia cells and human polymorphonuclear leukocytes. Blood. 1987 Aug;70(2):356–362. [PubMed] [Google Scholar]
  17. Malawista S. E., Duff G. W., Atkins E., Cheung H. S., McCarty D. J. Crystal-induced endogenous pyrogen production. A further look at gouty inflammation. Arthritis Rheum. 1985 Sep;28(9):1039–1046. doi: 10.1002/art.1780280911. [DOI] [PubMed] [Google Scholar]
  18. McColl S. R., DiPersio J. F., Caon A. C., Ho P., Naccache P. H. Involvement of tyrosine kinases in the activation of human peripheral blood neutrophils by granulocyte-macrophage colony-stimulating factor. Blood. 1991 Oct 1;78(7):1842–1852. [PubMed] [Google Scholar]
  19. Morrison D. K., Kaplan D. R., Escobedo J. A., Rapp U. R., Roberts T. M., Williams L. T. Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor. Cell. 1989 Aug 25;58(4):649–657. doi: 10.1016/0092-8674(89)90100-1. [DOI] [PubMed] [Google Scholar]
  20. Naccache P. H., Gilbert C., Caon A. C., Gaudry M., Huang C. K., Bonak V. A., Umezawa K., McColl S. R. Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinase. Blood. 1990 Nov 15;76(10):2098–2104. [PubMed] [Google Scholar]
  21. Naccache P. H., Grimard M., Roberge C. J., Gilbert C., Lussier A., de Médicis R., Poubelle P. E. Crystal-induced neutrophil activation. I. Initiation and modulation of calcium mobilization and superoxide production by microcrystals. Arthritis Rheum. 1991 Mar;34(3):333–342. doi: 10.1002/art.1780340311. [DOI] [PubMed] [Google Scholar]
  22. Onello E., Traynor-Kaplan A., Sklar L., Terkeltaub R. Mechanism of neutrophil activation by an unopsonized inflammatory particulate. Monosodium urate crystals induce pertussis toxin-insensitive hydrolysis of phosphatidylinositol 4,5-bisphosphate. J Immunol. 1991 Jun 15;146(12):4289–4294. [PubMed] [Google Scholar]
  23. Ouyang Y., Wang W., Bhuta S., Chang Y. H. Mechanism of action of colchicine. VI: Effect of colchicine on generation of leukotriene B4 by human polymorphonuclear leukocytes. Clin Exp Rheumatol. 1989 Jul-Aug;7(4):397–402. [PubMed] [Google Scholar]
  24. Phelps P. Polymorphonuclear leukocyte motility in vitro. 3. Possible release of a chemotactic substance after phagocytosis of urate crystals by polymorphonuclear leukocytes. Arthritis Rheum. 1969 Jun;12(3):197–204. doi: 10.1002/art.1780120306. [DOI] [PubMed] [Google Scholar]
  25. Poubelle P. E., De Medicis R., Naccache P. H. Monosodium urate and calcium pyrophosphate crystals differentially activate the excitation-response coupling sequence of human neutrophils. Biochem Biophys Res Commun. 1987 Dec 16;149(2):649–657. doi: 10.1016/0006-291x(87)90417-7. [DOI] [PubMed] [Google Scholar]
  26. Roberge C. J., Grassi J., De Médicis R., Frobert Y., Lussier A., Naccache P. H., Poubelle P. E. Crystal-neutrophil interactions lead to interleukin-1 synthesis. Agents Actions. 1991 Sep;34(1-2):38–41. doi: 10.1007/BF01993232. [DOI] [PubMed] [Google Scholar]
  27. Roch-Arveiller M., Legros R., Chanaud B., Muntaner O., Strzalko S., Thuret A., Willoughby D. A., Giroud J. P. Inflammatory reactions induced by various calcium pyrophosphate crystals. Biomed Pharmacother. 1990;44(9):467–474. doi: 10.1016/0753-3322(90)90207-p. [DOI] [PubMed] [Google Scholar]
  28. Schumacher H. R., Fishbein P., Phelps P., Tse R., Krauser R. Comparison of sodium urate and calcium pyrophosphate crystal phagocytosis by polymorphonuclear leukocytes. Effects of crystal size and other factors. Arthritis Rheum. 1975 Nov-Dec;18(6 Suppl):783–792. doi: 10.1002/art.1780180723. [DOI] [PubMed] [Google Scholar]
  29. Sharp J. D., White D. L., Chiou X. G., Goodson T., Gamboa G. C., McClure D., Burgett S., Hoskins J., Skatrud P. L., Sportsman J. R. Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J Biol Chem. 1991 Aug 15;266(23):14850–14853. [PubMed] [Google Scholar]
  30. Simchowitz L., Atkinson J. P., Spilberg I. Stimulation of the respiratory burst in human neutrophils by crystal phagocytosis. Arthritis Rheum. 1982 Feb;25(2):181–188. doi: 10.1002/art.1780250211. [DOI] [PubMed] [Google Scholar]
  31. Spilbert I., Gallacher A., Mehta J. M., Mandell B. Urate crystal-induced chemotactic factor: isolation and partial characterization. J Clin Invest. 1976 Oct;58(4):815–819. doi: 10.1172/JCI108533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Swan A., Dularay B., Dieppe P. A comparison of the effects of urate, hydroxyapatite and diamond crystals on polymorphonuclear cells: relationship of mediator release to the surface area and adsorptive capacity of different particles. J Rheumatol. 1990 Oct;17(10):1346–1352. [PubMed] [Google Scholar]
  33. Terkeltaub R. A., Sklar L. A., Mueller H. Neutrophil activation by inflammatory microcrystals of monosodium urate monohydrate utilizes pertussis toxin-insensitive and -sensitive pathways. J Immunol. 1990 Apr 1;144(7):2719–2724. [PubMed] [Google Scholar]
  34. Terkeltaub R., Zachariae C., Santoro D., Martin J., Peveri P., Matsushima K. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum. 1991 Jul;34(7):894–903. doi: 10.1002/art.1780340716. [DOI] [PubMed] [Google Scholar]
  35. de Médicis R., Lussier A., Kahan A., Tétreault L. Phagocytosis of sodium urate and calcium pyrophosphate crystals by leukocytes of gouty, pseudogouty and health donors. Eur J Rheumatol Inflamm. 1983;6(2):143–148. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES